Treatment of Molluscum Contagiosum
For healthy children and adults with few lesions, watchful waiting is reasonable as spontaneous resolution typically occurs within 6-12 months, but for symptomatic lesions, multiple lesions, periocular involvement, or immunocompromised patients, physical removal methods (curettage, excision, or cryotherapy) are first-line therapy. 1, 2, 3
Treatment Algorithm by Clinical Scenario
Limited Disease in Immunocompetent Patients
Watchful waiting is appropriate when:
- Lesions are asymptomatic 3
- Limited number of lesions present 3
- No periocular involvement 3
- Patient/family accepts natural course of 6-12 months (up to 4-5 years possible) 1, 3
Active treatment is indicated when:
- Lesions are symptomatic (painful, itchy, inflamed) 1, 3
- Multiple lesions present 1, 2, 3
- Lesions near eyes causing conjunctivitis 1, 2, 3
- Patient desires treatment to prevent autoinoculation and transmission 3, 4
- Cosmetic concerns (though warn that treatment may cause hyperpigmentation or scarring) 1, 4
First-Line Physical Removal Methods
Cryotherapy with liquid nitrogen:
- Achieves complete response in approximately 93% of cases 1, 3
- Apply until visible freezing extends slightly beyond lesion margin into normal skin 1
- Major caveat: Risk of postinflammatory hyperpigmentation (may persist 6-12 months) or scarring, particularly in darker skin tones 1, 3
- Avoid treating sensitive areas (eyelids, lips, nose, ears) due to higher complication risk 1
- No anesthesia typically needed 1
Curettage, excision, or excision with cautery:
- Equally effective first-line options recommended by the American Academy of Ophthalmology 1, 2, 3
- Particularly useful for periocular lesions 2, 3
First-Line Chemical Treatments (Children)
10% potassium hydroxide solution:
- Similar efficacy to cryotherapy (86.6% vs 93.3% complete response) 1
- Better cosmetic results with lower risk of hyperpigmentation compared to cryotherapy 1
- Recommended by the American Academy of Pediatrics as first-line chemical treatment 1, 3
Cantharidin:
- Creates controlled blistering that destroys infected epithelium 1
- Large retrospective review of 405 children showed no serious adverse events with 86% parent satisfaction 1
- Effectiveness demonstrated in observational studies though randomized controlled trial evidence is limited 1
Critical Treatment Principles
Identify and treat ALL lesions, including nascent ones:
- Reducing viral load allows host immune response to eliminate residual virus 1, 2
- Failure to treat early lesions is a common cause of recurrence 1
- Examine carefully for nascent lesions during initial treatment 1
Periocular lesions with conjunctivitis:
- Physical removal is imperative 1, 2
- Conjunctivitis may require several weeks to resolve after lesion elimination 1, 2
- Monitor for resolution at follow-up 2, 3
Extensive Disease or Immunocompromised Patients
Red flags suggesting immunocompromised state:
- Multiple large lesions with minimal inflammation 1, 2
- Giant, disseminated, necrotic, polypoidal, or nodular forms 1
- Extensive or recalcitrant disease 1
Management approach:
- Consider screening for HIV or other immunodeficiency 1, 5
- Refer to dermatology for examination of suspicious lesions 1, 2
- More aggressive treatment needed as spontaneous resolution is impaired 4, 6
Treatments to AVOID
Imiquimod:
- Not effective—showed no benefit compared to placebo in randomized controlled trials 1, 3
- Explicitly not recommended by the American Academy of Pediatrics 1, 3
Salicylic acid in young children:
- Contraindicated in children under 2 years due to risk of systemic toxicity 3
Age-Specific Considerations
Children:
- Physical removal or 10% potassium hydroxide are preferred first-line options 1, 3
- Cryotherapy effective but higher risk of cosmetic complications 1, 3
- Hand hygiene is most important prevention method 1, 3
- Cover lesions with waterproof bandages if water exposure unavoidable 1, 3
Adults:
- Same physical removal methods (curettage, excision, cryotherapy) recommended 2
- Genital lesions warrant treatment to reduce sexual transmission risk 6
- Follow-up not usually necessary unless conjunctivitis persists or new lesions develop 2
Common Pitfalls
- Missing nascent lesions during initial treatment leads to recurrence 1
- Undertreating periocular lesions can result in persistent conjunctivitis 1, 2
- Not recognizing immunocompromised state when multiple large lesions present with minimal inflammation 1, 2, 5
- Using imiquimod despite lack of evidence for efficacy 1, 3
- Expecting immediate resolution of conjunctivitis after lesion removal—may take weeks 1, 2